Vijaya Diagnostic Centre · NSE: VIJAYA · BSE: 543350

Q2 FY25 results · Jul–Sep 2024

Vijaya Diagnostic Centre reported revenue from operations of ₹182.95 crore (up 31.8% from Q2 FY24) and net profit of ₹42.12 crore (up 25.5% from Q2 FY24) for Q2 FY25 (Jul–Sep 2024), on a consolidated basis.

Consolidated · ₹ crore
ItemQ2 FY25Q2 FY24YoYQ1 FY25QoQ
Revenue from operations182.95138.86+31.8%156.22+17.1%
Other income4.516.75−33.2%3.56+26.5%
Total income187.46145.61+28.7%159.78+17.3%
Profit before tax57.1944.58+28.3%41.90+36.5%
Net profit for the period42.1233.57+25.5%31.51+33.7%
Attributable to shareholders of the company41.9433.32+25.9%31.35+33.8%
EPS, basic (₹)4.093.26+25.5%3.06+33.7%
Net margin (%)23.024.220.2
Standalone · ₹ crore
ItemQ2 FY25Q2 FY24YoYQ1 FY25QoQ
Revenue from operations168.61136.13+23.9%142.42+18.4%
Other income4.806.92−30.5%3.83+25.6%
Total income173.41143.04+21.2%146.25+18.6%
Profit before tax53.5343.79+22.2%38.31+39.7%
Net profit for the period39.5032.85+20.2%28.86+36.8%
EPS, basic (₹)3.853.21+19.9%2.82+36.5%
Net margin (%)23.424.120.3
Consolidated
Filed with BSE
07 Nov 2024, 16:57 IST
Board meeting
07 Nov 2024
Period
01 Jul 2024 to 30 Sep 2024
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
07 Nov 2024, 16:57 IST
Board meeting
07 Nov 2024
Period
01 Jul 2024 to 30 Sep 2024
Review status
Unaudited
Source
XBRL filing on BSE